190 related articles for article (PubMed ID: 17725581)
1. RGS9-2 is a negative modulator of mu-opioid receptor function.
Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
[TBL] [Abstract][Full Text] [Related]
2. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.
Psifogeorgou K; Terzi D; Papachatzaki MM; Varidaki A; Ferguson D; Gold SJ; Zachariou V
J Neurosci; 2011 Apr; 31(15):5617-24. PubMed ID: 21490202
[TBL] [Abstract][Full Text] [Related]
3. Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization.
Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
J Biol Chem; 2005 Mar; 280(10):8951-60. PubMed ID: 15632124
[TBL] [Abstract][Full Text] [Related]
4. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
5. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
[TBL] [Abstract][Full Text] [Related]
6. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
7. Essential role for RGS9 in opiate action.
Zachariou V; Georgescu D; Sanchez N; Rahman Z; DiLeone R; Berton O; Neve RL; Sim-Selley LJ; Selley DE; Gold SJ; Nestler EJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13656-61. PubMed ID: 14595021
[TBL] [Abstract][Full Text] [Related]
8. Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.
Quillinan N; Lau EK; Virk M; von Zastrow M; Williams JT
J Neurosci; 2011 Mar; 31(12):4434-43. PubMed ID: 21430144
[TBL] [Abstract][Full Text] [Related]
9. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; Garzón J
Neuropharmacology; 2005 Jan; 48(1):134-50. PubMed ID: 15617734
[TBL] [Abstract][Full Text] [Related]
10. Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IκB kinase activation and SNAP-23 phosphorylation: correlation with the formation of a β-arrestin/TRAF6 complex.
Madera-Salcedo IK; Cruz SL; Gonzalez-Espinosa C
J Immunol; 2013 Sep; 191(6):3400-9. PubMed ID: 23960234
[TBL] [Abstract][Full Text] [Related]
11. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
[TBL] [Abstract][Full Text] [Related]
12. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
[TBL] [Abstract][Full Text] [Related]
13. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
14. Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons.
Dang VC; Chieng BC; Christie MJ
Mol Pharmacol; 2012 Sep; 82(3):473-80. PubMed ID: 22689562
[TBL] [Abstract][Full Text] [Related]
15. Expression of neural RGS-R7 and Gbeta5 Proteins in Response to Acute and Chronic Morphine.
López-Fando A; Rodríguez-Muñoz M; Sánchez-Blázquez P; Garzón J
Neuropsychopharmacology; 2005 Jan; 30(1):99-110. PubMed ID: 15199376
[TBL] [Abstract][Full Text] [Related]
16. The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects.
Sánchez-Blázquez P; Rodríguez-Díaz M; López-Fando A; Rodríguez-Muñoz M; Garzón J
Neuropharmacology; 2003 Jul; 45(1):82-95. PubMed ID: 12814661
[TBL] [Abstract][Full Text] [Related]
17. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
[TBL] [Abstract][Full Text] [Related]
18. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.
Urs NM; Daigle TL; Caron MG
Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993
[TBL] [Abstract][Full Text] [Related]
19. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
[TBL] [Abstract][Full Text] [Related]
20. The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors.
Garzón J; López-Fando A; Sánchez-Blázquez P
Neuropsychopharmacology; 2003 Nov; 28(11):1983-90. PubMed ID: 12902995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
